ALA 0.00% 15.5¢ arovella therapeutics limited

Are you paying attention?

  1. 30,779 Posts.
    lightbulb Created with Sketch. 711
    SUDA'S position as the only company across the world holding a patent covering the use of Anagrelide for treating or preventing metastatic disease in the lung or bone in patients with solid cancers and high platelet count. "
    The patent expires in 2035

    We now know why Mr Hopper is excited!!
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.